Literature DB >> 36262769

Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China.

Yang Yang1,2, Jie Zhang3, Liqun Fang2, Xue Jia1,2, Wensheng Zhang1,2.   

Abstract

Purpose: Alpha-adrenergic blockers are used in the preoperative preparation of patients with pheochromocytomas and paragangliomas (PPGLs) despite the controversial on perioperative hemodynamics. We aimed to determine whether selective or non-selective α-adrenergic blockers can provide better efficacy on patients' intraoperative hemodynamics. Patients and
Methods: This single-center retrospective study was conducted in 2507 adult patients undergoing PPGL resections, patients received alpha-adrenergic receptor blockers as a binary variable (selective or non-selective). Propensity score matching was performed and 201 patients were matched successfully.
Results: A total of 201 patients with PPGL were included in this study. The HI score scores were higher in the selective group than in the non-selective group (60.5 [44.5-84.0] vs 49.0 [37.0-67.25], P=0.027), as well as in the hemodynamic variables section [14.0 [8.0-20.0] vs 10 [6.0-16.0], P=0.009). In terms of specific indicators for each component, the lowest MAP in the selective group (55±10 mmHg vs 59±8 mmHg, P=0.038), the time to MAP below 60 mmHg (0.011% vs 0.022%, P=0.033) and the use of other vasoconstrictors (56.5% vs 35.5%, P=0.019) were significantly lower than in the non-selective group. Among the secondary outcome indicators, the incidence of intraoperative maximum SBP was significantly higher in the selective group than in the non-selective group (32.3% vs 11.3%, P=0.005). There were no significant differences in postoperative outcome indicators between the two groups.
Conclusion: In patients with PPGL, patients prepared preoperatively with non-selective alpha-blockers presented more stable hemodynamics intraoperatively compared to selective alpha1-blockers.
© 2022 Yang et al.

Entities:  

Keywords:  PPGLs; hemodynamic instability; perioperative management; α-adrenergic blockers

Mesh:

Substances:

Year:  2022        PMID: 36262769      PMCID: PMC9574264          DOI: 10.2147/DDDT.S378796

Source DB:  PubMed          Journal:  Drug Des Devel Ther        ISSN: 1177-8881            Impact factor:   4.319


  24 in total

Review 1.  Pheochromocytoma and Paraganglioma.

Authors:  Hartmut P H Neumann; William F Young; Charis Eng
Journal:  N Engl J Med       Date:  2019-08-08       Impact factor: 91.245

2.  Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades.

Authors:  Margaret Livingstone; Kaylene Duttchen; Jenny Thompson; Zahid Sunderani; Geoffrey Hawboldt; M Sarah Rose; Janice Pasieka
Journal:  Ann Surg Oncol       Date:  2015-03-31       Impact factor: 5.344

3.  Preoperative risk factors for haemodynamic instability during pheochromocytoma surgery in Chinese patients.

Authors:  Minchun Jiang; Huanyu Ding; Ying Liang; Juying Tang; Ying Lin; Kexu Xiang; Ying Guo; Shaoling Zhang
Journal:  Clin Endocrinol (Oxf)       Date:  2018-01-25       Impact factor: 3.478

4.  CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.

Authors:  Hana Turkova; Tamara Prodanov; Marek Maly; Victoria Martucci; Karen Adams; Jiri Widimsky; Clara C Chen; Alexander Ling; Electron Kebebew; Constantine A Stratakis; Tito Fojo; Karel Pacak
Journal:  Endocr Pract       Date:  2015-11-02       Impact factor: 3.443

Review 5.  Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.

Authors:  Jacques W M Lenders; Michiel N Kerstens; Laurence Amar; Aleksander Prejbisz; Mercedes Robledo; David Taieb; Karel Pacak; Joakim Crona; Tomáš Zelinka; Massimo Mannelli; Timo Deutschbein; Henri J L M Timmers; Frederic Castinetti; Henning Dralle; Jřri Widimský; Anne-Paule Gimenez-Roqueplo; Graeme Eisenhofer
Journal:  J Hypertens       Date:  2020-08       Impact factor: 4.844

6.  Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma.

Authors:  Lulu Ma; Le Shen; Xiuhua Zhang; Yuguang Huang
Journal:  J Surg Oncol       Date:  2020-06-20       Impact factor: 3.454

7.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2009-11-10       Impact factor: 2.373

8.  Preoperative selective vs non-selective α-blockade in PPGL patients undergoing adrenalectomy.

Authors:  Caojie Liu; Qingguo Lv; Xinlei Chen; Guangcheng Ni; Liru Hu; Nanwei Tong; Yuwei Zhang
Journal:  Endocr Connect       Date:  2017-10-06       Impact factor: 3.335

9.  Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.

Authors:  Edward Buitenwerf; Thamara E Osinga; Henri J L M Timmers; Jacques W M Lenders; Richard A Feelders; Elisabeth M W Eekhoff; Harm R Haak; Eleonora P M Corssmit; Peter H L T Bisschop; Gerlof D Valk; Ronald Groote Veldman; Robin P F Dullaart; Thera P Links; Magiel F Voogd; Götz J K G Wietasch; Michiel N Kerstens
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

10.  Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.

Authors:  Jung Hee Kim; Hyemi Moon; Junghyun Noh; Juneyoung Lee; Sin Gon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.